MGMT and central nervous system cancer: Benefitting from the recognition of glioma biomarkers such as O6-methylguananine–DNA methyltransferase (MGMT) and epidermal growth factor receptor, patients with glioma have been diagnosed as early as possible, but the overall 5-year survival rate is still far from satisfaction25,26.